Clinical Trial Update: Gemcitabine in Treating Patients With Recurrent or Metastatic Adenoid Cystic Cancer of the Head and Neck [Phase 2]

View source ↗

Summary

This document notes a Phase 2 trial of gemcitabine for recurrent or metastatic adenoid cystic carcinoma of the head and neck, with the study status listed as co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenoid Cystic Carcinoma of the Head and Neck
• Head and Neck Cancer

Drugs mentioned

• Gemzar (gemcitabine)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED